Eli Lilly has committed to setting a new standard for on-screen representation of common chronic diseases, and it walked the walk with its recent sponsorship of a segment on “Project Runway.” In the ...
American pharmaceutical giant Eli Lilly and Company is investing over $1 billion (approx Rs 8,900 crore) in India to establish new contract manufacturing facilities, including a significant hub in ...
Eli Lilly and Company on Monday (October 6, 2025) said it will invest more than $1 billion over the next several years into new contract manufacturing, as well as establish in Hyderabad a new facility ...
Eli Lilly & Co., the maker of the blockbuster Mounjaro diabetes drug, plans to invest more than $1 billion for contract manufacturing in India, amid 100% US tariff on the pharma sector. Eli Lilly, ...
Mounjaro and Zepbound have helped boost the company's market cap. New data indicate these drugs do more than just help patients lose weight, contributing to potentially lowering risks to hearts and ...
Eli Lilly and Company (NYSE:LLY) is one of the best medical stocks to buy now. In a report released on September 26, CFRA upgraded Eli Lilly and Company (NYSE:LLY) to a Buy, setting a price target of ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — Riding high on the success of its blockbuster weight loss drug, Eli ...
Corey Dambacher was working in Oregon when he discovered a type of ribonucleic acid capable of creating unique types of proteins that express themselves on the surfaces of cancer cells. It’s just the ...
Eli Lilly has pulled the plug on a phase 2b obesity trial before enrolling a single patient, citing “strategic business reasons.” The study was designed to test bimagrumab, an asset Lilly acquired in ...
Sept. 23 (UPI) --Indianapolis-based Eli Lilly intends to build a biomanufacturing facility that would cost $6.5 billion to build and employ 4,000 construction workers in the greater Houston area.
Eli Lilly has been censured by the U.K. marketing watchdog after a complainant reported being hit by a “bombardment of spam.” The complainant contacted the U.K.’s self-regulatory body, the PMCPA, ...
Lilly's orforglipron shows superior weight loss and blood sugar control Highest dose of the pill leads to 9.2% weight reduction Detailed trial results to be presented at future medical meeting The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results